World-Renowned Fetal Surgeon Joins University of Miami/Jackson

peopleThe University of Miami/Jackson is one of the few hospitals in the country that offers fetal therapy services—and with the arrival of world-renowned fetal surgeon Rubén A. Quintero, M.D., the University is primed to become a leading national center for fetal medicine.

Ruebén A. Quintero, M.D., specializes in treating life-threatening disorders in unborn babies.

Quintero joined the Miller School of Medicine and Women’s Hospital Center at Jackson Memorial Hospital on March 1 as director of the Division of Maternal-Fetal Medicine and professor of obstetrics and gynecology. At the University of Miami/Jackson, Quintero will launch a unique fetal therapy program that will help previously untreatable, life-threatening disorders discovered in unborn babies.

“The addition of Dr. Quintero to our team of maternal-fetal medicine specialists will result in a true transformation of the services we will be able to offer our pregnant patients,” says Leo B. Twiggs, M.D., professor and chair of obstetrics and gynecology at the Miller School. “This is a great opportunity to build on the quality of care at the Women’s Hospital Center at Jackson Memorial and UHealth–University of Miami Health System. His addition will also complement our internationally renowned neonatal and pediatrics program at Holtz Children’s Hospital.”

Quintero is a leader in the maternal-fetal subspecialty that’s existed since 1980. He is best known for developing a minimally invasive approach for the correction of birth defects in utero, also known as Operative Fetoscopy. He has also developed the selective laser technique to treat twin-to-twin transfusion syndrome (TTTS), a condition resulting from the unbalanced flow of blood between two fetuses sharing a common placenta.

“I am very excited about joining the Miller School and Women’s Hospital Center at Jackson Memorial Hospital,” Quintero says. “This is a unique opportunity and an unparalleled venue that will allow us, among other things, to take fetal therapy to a new level.”